rimonabant protective_against obesity

Subject: rimonabant
Relation: protective_against
Object: obesity
p-value: —

Evidence from: primary | all sources

Evidence (1 sources)

Shared genetic risk between eating disorder- and substance-use-related phenotypes: Evidence from genome-wide association studies. (2021) PMID:32064741 primary

Rimonabant ... tested as a highly promising anti-obesity medication

confidence: 0.80